These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12419059)

  • 1. An assessment of the use of Implanon in three community services.
    Smith A; Reuter S
    J Fam Plann Reprod Health Care; 2002 Oct; 28(4):193-6. PubMed ID: 12419059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implanon. The new alternative.
    Cherry S
    Aust Fam Physician; 2002 Oct; 31(10):897-900. PubMed ID: 12404826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implanon sub-dermal implants: a 10-month review of acceptability in Jos, North-Central Nigeria.
    Mutihir JT; Daru PH
    Niger J Clin Pract; 2008 Dec; 11(4):320-3. PubMed ID: 19320403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insertion and removal of Implanon: practical considerations.
    Mascarenhas L
    Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():29-34. PubMed ID: 11246605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.
    Zheng SR; Zheng HM; Qian SZ; Sang GW; Kaper RF
    Contraception; 1999 Jul; 60(1):1-8. PubMed ID: 10549446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia.
    Harvey C; Seib C; Lucke J
    Contraception; 2009 Dec; 80(6):527-32. PubMed ID: 19913146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of Implanon on lipid metabolism in comparison with Norplant.
    Suherman SK; Affandi B; Korver T
    Contraception; 1999 Nov; 60(5):281-7. PubMed ID: 10717780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuation rates of the subdermal contraceptive Implanon(®) and associated influencing factors.
    Teunissen AM; Grimm B; Roumen FJ
    Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):15-21. PubMed ID: 24329119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Implanon insertion and removal.
    Levine JP; Sinofsky FE; Christ MF;
    Contraception; 2008 Nov; 78(5):409-17. PubMed ID: 18929739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing unmet need for long-acting family planning in Ethiopia: uptake of single-rod progestogen contraceptive implants (Implanon) and characteristics of users.
    Asnake M; Henry EG; Tilahun Y; Oliveras E
    Int J Gynaecol Obstet; 2013 Nov; 123 Suppl 1():e29-32. PubMed ID: 24035007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuation rates of Implanon in the UK: data from an observational study in a clinical setting.
    Lakha F; Glasier AF
    Contraception; 2006 Oct; 74(4):287-9. PubMed ID: 16982226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reasons for requesting removal of the hormonal implant, Implanon NXT, at an urban reproductive health clinic in KwaZulu-Natal, South Africa.
    Beesham I; Smit J; Beksinska M; Panday M; Makatini V; Evans S
    S Afr Med J; 2019 Sep; 109(10):750-755. PubMed ID: 31635572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 4-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand.
    Kiriwat O; Patanayindee A; Koetsawang S; Korver T; Bennink HJ
    Eur J Contracept Reprod Health Care; 1998 Jun; 3(2):85-91. PubMed ID: 9710712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impalpable Implanon: a case report.
    Stillwell S; Sheppard P; Searle S
    J Fam Plann Reprod Health Care; 2003 Jul; 29(3):156-7. PubMed ID: 12885313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and acceptability of using medical and nursing students to provide Implanon NXT at the community level in Kinshasa, Democratic Republic of Congo.
    Hernandez JH; Akilimali P; Glover A; Bertrand JT
    BMC Womens Health; 2020 Jun; 20(1):133. PubMed ID: 32580766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of the first 3 years' use of Implanon in Luton.
    Agrawal A; Robinson C
    J Fam Plann Reprod Health Care; 2005 Oct; 31(4):310-2. PubMed ID: 16274557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women's contraceptive choice following the use of Implanon NXT: Findings from a study in Durban, South Africa.
    Beesham I; Smit J; Bosman SL; Milford C; Panday M; Beksinska M
    Afr J Reprod Health; 2021 Feb; 25(1):41-48. PubMed ID: 34077109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reasons for Discontinuation of Implanon among Users in Buffalo City Metropolitan Municipality, South Africa: A Cross-Sectional Study.
    Mrwebi KP; Goon DT; Owolabi EO; Adeniyi OV; Seekoe E; Ajayi AI
    Afr J Reprod Health; 2018 Mar; 22(1):113-119. PubMed ID: 29777648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contraceptive implants--aberrations from insertion and removal procedures].
    Jørgensen NP
    Tidsskr Nor Laegeforen; 2010 Apr; 130(7):733-4. PubMed ID: 20379334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with Implanon in a northeast London family planning clinic.
    Rai K; Gupta S; Cotter S
    Eur J Contracept Reprod Health Care; 2004 Mar; 9(1):39-46. PubMed ID: 15352694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.